Akbik Feras, Shi Yuyang, Philips Steven, Pimentel-Farias Cederic, Grossberg Jonathan A, Howard Brian M, Tong Frank, Cawley C Michael, Samuels Owen B, Mei Yajun, Sadan Ofer
Division of Neurocritical Care, Department of Neurology and Neurosurgery, Emory University School of Medicine, 1364 Clifton Rd NE, Atlanta, GA, 30322, USA.
H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
Neurocrit Care. 2025 Jun;42(3):929-936. doi: 10.1007/s12028-024-02173-1. Epub 2024 Nov 26.
Classic teaching in neurocritical care is to avoid jugular access for central venous catheterization (CVC) because of a presumed risk of increasing intracranial pressure (ICP). Limited data exist to test this hypothesis. Aneurysmal subarachnoid hemorrhage (aSAH) leads to diffuse cerebral edema and often requires external ventricular drains (EVDs), which provide direct ICP measurements. Here, we test whether CVC access site correlates with ICP measurements and catheter-associated complications in patients with aSAH.
In a single-center retrospective cohort study, patients with aSAH admitted to Emory University Hospital between January 1, 2012, through December 31, 2020, were included. Patients were assigned by the access site of the first CVC placed. The subset of patients with an EVD were further studied. ICP measurements were analyzed using linear mixed effect models, with a binary comparison between internal-jugular (IJ) versus non-IJ access.
A total of 1577 patients were admitted during the study period with CVC access: subclavian (SC) (887, 56.2%), IJ (365, 23.1%), femoral (72, 4.6%), and peripheral inserted central catheter (PICC) (253, 16.0%). Traumatic pneumothorax was the most common with SC access (3.0%, p < 0.01). Catheter-associated infections did not differ between sites. Catheter-associated deep venous thrombosis was most common in femoral (8.3%) and PICC (3.6%) access (p < 0.05). A total of 1220 patients had an EVD, remained open by default, generating 351,462 ICP measurements. ICP measurements, as compared over the first 24-postinsertion hours and the next 10 days, were similar between the two groups. Subgroup analysis accounting for World Federation of Neurological Surgeons grade on presentation yielded similar results.
Contrary to classic teaching, we find that IJ CVC placement was not associated with increased ICP in the clinical context of the largest, quantitative data set to date. Further, IJ access was the least likely to be associated with an access-site complication when compared with SC, femoral, and PICC. Together, these data support the safety, and perhaps preference, of ultrasound-guided IJ venous catheterization in neurocritically ill patients.
神经重症监护的传统教学认为,由于存在颅内压(ICP)升高的潜在风险,应避免通过颈静脉途径进行中心静脉置管(CVC)。但用于验证该假设的数据有限。动脉瘤性蛛网膜下腔出血(aSAH)会导致弥漫性脑水肿,通常需要进行脑室外引流(EVD),以直接测量颅内压。在此,我们测试aSAH患者的CVC置管部位与颅内压测量值及导管相关并发症之间是否存在关联。
在一项单中心回顾性队列研究中,纳入了2012年1月1日至2020年12月31日期间入住埃默里大学医院的aSAH患者。根据首次放置CVC的部位对患者进行分组。对放置EVD的患者亚组进行进一步研究。使用线性混合效应模型分析颅内压测量值,对颈内静脉(IJ)置管与非IJ置管进行二元比较。
在研究期间,共有1577例患者接受了CVC置管:锁骨下静脉(SC)置管887例(56.2%),IJ置管365例(23.1%),股静脉置管72例(4.6%),外周静脉穿刺中心静脉置管(PICC)253例(16.0%)。锁骨下静脉置管最常见的并发症是创伤性气胸(3.0%,p < 0.01)。各部位导管相关感染无差异。导管相关深静脉血栓形成在股静脉置管(8.3%)和PICC置管(3.6%)中最为常见(p < 0.05)。共有1220例患者放置了EVD,默认情况下EVD保持开放,共产生351462次颅内压测量值。在前24小时和接下来10天的颅内压测量值比较中,两组相似。根据世界神经外科联合会分级进行亚组分析也得到了类似结果。
与传统教学观点相反,我们发现,在迄今为止最大的定量数据集的临床背景下,IJ途径进行CVC置管与颅内压升高无关。此外,与SC、股静脉和PICC置管相比,IJ途径与置管部位并发症的关联最小。总之,这些数据支持了在神经重症患者中超声引导下IJ静脉置管的安全性,甚至可能更具优势。